NASDAQ:ESTA Establishment Labs (ESTA) Stock Price, News & Analysis $34.64 -0.04 (-0.12%) Closing price 05/30/2025 04:00 PM EasternExtended Trading$34.83 +0.19 (+0.55%) As of 05/30/2025 05:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Establishment Labs Stock (NASDAQ:ESTA) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Establishment Labs alerts:Sign Up Key Stats Today's Range$33.51▼$35.1050-Day Range$27.31▼$41.5952-Week Range$26.56▼$58.00Volume445,316 shsAverage Volume475,250 shsMarket Capitalization$1.00 billionP/E RatioN/ADividend YieldN/APrice Target$55.33Consensus RatingModerate Buy Company OverviewEstablishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander. The company sells its products to physicians, hospitals, and clinics through distributors and direct sales force in Europe, the Middle East, Latin America, and Asia. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.Read More… Establishment Labs Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks63rd Percentile Overall ScoreESTA MarketRank™: Establishment Labs scored higher than 63% of companies evaluated by MarketBeat, and ranked 382nd out of 934 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.4 / 5Analyst RatingModerate Buy Consensus RatingEstablishment Labs has received a consensus rating of Moderate Buy. The company's average rating score is 2.83, and is based on 5 buy ratings, 1 hold rating, and no sell ratings.Amount of Analyst CoverageEstablishment Labs has only been the subject of 3 research reports in the past 90 days.Read more about Establishment Labs' stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Establishment Labs are expected to grow in the coming year, from ($2.41) to ($1.83) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Establishment Labs is -13.43, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Establishment Labs is -13.43, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioEstablishment Labs has a P/B Ratio of 48.79. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Establishment Labs' valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted17.14% of the float of Establishment Labs has been sold short.Short Interest Ratio / Days to CoverEstablishment Labs has a short interest ratio ("days to cover") of 7.3.Change versus previous monthShort interest in Establishment Labs has recently decreased by 8.99%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldEstablishment Labs does not currently pay a dividend.Dividend GrowthEstablishment Labs does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted17.14% of the float of Establishment Labs has been sold short.Short Interest Ratio / Days to CoverEstablishment Labs has a short interest ratio ("days to cover") of 7.3.Change versus previous monthShort interest in Establishment Labs has recently decreased by 8.99%, indicating that investor sentiment is improving significantly. News and Social Media4.1 / 5News Sentiment1.31 News SentimentEstablishment Labs has a news sentiment score of 1.31. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.87 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 5 news articles for Establishment Labs this week, compared to 4 articles on an average week.Search Interest3 people have searched for ESTA on MarketBeat in the last 30 days. MarketBeat Follows4 people have added Establishment Labs to their MarketBeat watchlist in the last 30 days. Company Ownership2.5 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Establishment Labs insiders have not sold or bought any company stock.Percentage Held by Insiders11.09% of the stock of Establishment Labs is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions72.91% of the stock of Establishment Labs is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Establishment Labs' insider trading history. Receive ESTA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Establishment Labs and its competitors with MarketBeat's FREE daily newsletter. Email Address ESTA Stock News HeadlinesEstablishment Labs Hldgs Earnings Estimates, EPS & Revenue | NASDAQ:ESTA | BenzingaMay 15, 2025 | benzinga.comNeedham Upgrades Establishment Labs Holdings (ESTA)May 14, 2025 | msn.comTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.May 31, 2025 | Porter & Company (Ad)Establishment Labs rises as Needham upgrades on easing trade warMay 14, 2025 | msn.comEstablishment Labs Holdings, Inc. (ESTA) Q1 2025 Earnings Call TranscriptMay 10, 2025 | seekingalpha.comEstablishment Labs stock holds as Needham maintains ratingMay 10, 2025 | uk.investing.comQ1 2025 Establishment Labs Holdings Inc Earnings CallMay 10, 2025 | finance.yahoo.comEstablishment Labs Appoints Peter Caldini as Chief Executive OfficerMay 7, 2025 | finance.yahoo.comSee More Headlines ESTA Stock Analysis - Frequently Asked Questions How have ESTA shares performed this year? Establishment Labs' stock was trading at $46.07 on January 1st, 2025. Since then, ESTA stock has decreased by 24.8% and is now trading at $34.64. View the best growth stocks for 2025 here. How were Establishment Labs' earnings last quarter? Establishment Labs Holdings Inc. (NASDAQ:ESTA) released its quarterly earnings results on Wednesday, May, 7th. The company reported ($0.70) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.83) by $0.13. Establishment Labs's revenue was up 11.3% compared to the same quarter last year. Read the conference call transcript. When did Establishment Labs IPO? Establishment Labs (ESTA) raised $50 million in an initial public offering on Thursday, July 19th 2018. The company issued 3,100,000 shares at $15.00-$17.00 per share. Jefferies and Cowen acted as the underwriters for the IPO and BTIG was co-manager. Who are Establishment Labs' major shareholders? Establishment Labs' top institutional shareholders include Brown Advisory Inc. (7.95%), Nantahala Capital Management LLC (6.13%), Rice Hall James & Associates LLC (2.87%) and Boothbay Fund Management LLC (1.83%). Insiders that own company stock include Nicholas Sheridan Lewin, Quiros Juan Jose Chacon, Raj Denhoy, Raj Denhoy and Leslie Gillin. View institutional ownership trends. How do I buy shares of Establishment Labs? Shares of ESTA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Establishment Labs own? Based on aggregate information from My MarketBeat watchlists, some other companies that Establishment Labs investors own include PayPal (PYPL), NVIDIA (NVDA), Walt Disney (DIS), Meta Platforms (META), Tesla (TSLA), Advanced Micro Devices (AMD) and Intel (INTC). Company Calendar Last Earnings5/07/2025Today5/30/2025Next Earnings (Estimated)8/05/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical appliances & supplies Sub-IndustryMedical Equipment Current SymbolNASDAQ:ESTA CIK1688757 Webwww.establishmentlabs.com Phone(062) 434-2400FaxN/AEmployees960Year FoundedN/APrice Target and Rating Average Stock Price Target$55.33 High Stock Price Target$70.00 Low Stock Price Target$48.00 Potential Upside/Downside+59.7%Consensus RatingModerate Buy Rating Score (0-4)2.83 Research Coverage6 Analysts Profitability EPS (Most Recent Fiscal Year)($3.10) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$78.50 million Net Margins-46.13% Pretax Margin-46.87% Return on Equity-184.55% Return on Assets-24.81% Debt Debt-to-Equity Ratio5.94 Current Ratio3.62 Quick Ratio2.29 Sales & Book Value Annual Sales$170.24 million Price / Sales5.88 Cash FlowN/A Price / Cash FlowN/A Book Value$0.71 per share Price / Book48.79Miscellaneous Outstanding Shares28,917,000Free Float24,795,000Market Cap$1.00 billion OptionableOptionable Beta0.73 20 Stocks to Sell NowToday, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.Get This Free Report This page (NASDAQ:ESTA) was last updated on 5/31/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredAs Bitcoin supply vanishes, this Trump-aligned token could explodeBitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Establishment Labs Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Establishment Labs With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.